CANCTema Oncology ETF
Seeks to provide long-term growth.
Tema Global Limited · Since 2023 (2 years)
0.75%
#3579 out of 5,332 ETFs
$168M
#2247 out of 5,332 ETFs
0.05%
2 years
#3201 out of 5,332 ETFs
Performance
1 Year
+48.8%
3 Years
N/A
5 Years
N/A
What's inside
Asset allocation
Sector breakdown
Top holdings
Risk profile
24.8%
High
-28.2%
Worst peak-to-trough loss
N/A
N/A
Similar ETFs
Our take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
Thematic ETF — launched after the rally
Thematic funds are typically launched after a theme has delivered its strong returns. Morningstar's 2024 Global Thematic Funds Landscape finds that only about 1 in 10 thematic funds have survived and beaten a broad global equity benchmark over the past 15 years — roughly 60% have been closed outright. The narrative is always compelling; the track record rarely is.
Source: Morningstar, 'Global Thematic Funds Landscape' (2024)
Why we flagged this: Narrow thematic name, launched in the last 3 years, $168M in assets (under our $500M threshold).
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
Data updated on 2026-05-05